Companies
Danaher
Life sciences toolsWashington, D.C.DHRAbout 60,000 employees
More about Danaher
Holding company for life sciences, diagnostics and bioprocessing businesses that sell instruments, consumables and services
Revenue
$24.6B
Fiscal 2025, up about 3%
Employees
About 60,000
As of December 2025
Stock
DHR
New York Stock Exchange
Headquarters
Washington, D.C.
CEO
Julie Sawyer Montgomery
Since October 2026, succeeding Rainer Blair
Main businessesBiotechnology (Cytiva, Pall), Life Sciences, Diagnostics (Beckman Coulter, Cepheid)
Current strategyApplying the Danaher Business System and building its portfolio in science and technology markets through acquisitions and capital allocation
Recent workforce changes85 roles cut at Cytiva's Westborough, Massachusetts site in March 2025
CompetitorsThermo Fisher Scientific, Sartorius, Roche
Related companiesThermo Fisher ScientificAgilent TechnologiesWaters
Checked October 11, 2026 · Sources: sec.gov, sec.gov (2), fiercepharma.com
No source-backed updates for Danaher yet. They appear here when a public report or filing covers the company.
No one has posted about Danaher yet. Be the first to post ›
Follow Danaher in a feed reader, no account needed: RSS feed